Technology ID
TAB-3694
Development of monoclonal antibodies that detect specific forms of neurophysin bound to either vasopressin or oxytocin
E-Numbers
E-004-2014-0
Lead Inventor
Gainer, Harold (Estate of) (National Institute of Neurological Disorders and Stroke)
Applications
Research Materials
Therapeutic Areas
Neurology
Immunology
Endocrinology
Research Products
Antibodies
Lead IC
NINDS
This invention includes the generation and use of monoclonal antibodies that specifically recognize either arginine vasopressin (AVP) or oxytocin (OT) when bound to neurophysins. The neurophysins (NPs) are a family of proteins that bind to hormones as they are released from the hypothalamus and make their way to the pituitary gland. Monoclonal antibodies were generated that specifically recognize vasopressin bound to a neurophysin (NP-AVP) or oxytocin bound to a neurophysin (NP-OT). Seven monoclonal antibodies were characterized. The PS41 and PS45 antibodies were found to specifically detect NP-AVP and the PS38 antibody specifically detects NP-OT.
Commercial Applications
The monoclonal antibodies can be used in R1A, immunoblot, and immunohistochemistry assays to detect specific forms of neurophysin bound to either vasopressin or oxytocin.
Competitive Advantages
No other antibody with these specificities exists commercially.
Licensing Contact: